Lanthionine ketimine ester improves outcome in an MPTP-induced mouse model of Parkinson's disease via suppressions of CRMP2 phosphorylation and microglial activation
Kentaro Togashi(Waseda University), Toshio Ohshima(Waseda University), Jun Nagai(Waseda University), Yoshio Goshima(Yokohama University of Pharmacy), Ken Kotaka(Waseda University), Miyuki Takahashi(Waseda University), Masaya Hasegawa(Waseda University), Arina Yazawa(Waseda University), Kenneth Hensley(University of Arkansas – Fort Smith), Daiki Masukawa(Yokohama City University)
Cited by 10
Related Papers
Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death.
|Proceedings of the National Academy of Sciences|1996|900
Electrochemical Analysis of Protein Nitrotyrosine and Dityrosine in the Alzheimer Brain Indicates Region-Specific Accumulation
|Journal of Neuroscience|1998|510
Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3β phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease
|Genes to Cells|2005|411
α-Galactosidase A deficient mice: A model of Fabry disease
|Proceedings of the National Academy of Sciences|1997|370
Gene Expression Patterns of Murine Dentin Matrix Protein 1 (Dmp1) and Dentin Sialophosphoprotein (DSPP) Suggest Distinct Developmental Functions In Vivo
|Journal of Bone and Mineral Research|1997|348